UPDATE 1-Achaogen's lead antibiotic succeeds in two key studies

Dec 12 (Reuters) - Achaogen Inc's plazomicin, being developed to fight multi-drug resistant bacterial infections, was successful in two pivotal studies, prompting the company to proceed with... [Source]

Publication Date: Monday, 12 December 2016 at 14:57:35

Origin: reuters.com

Category: hotStocksNews

Topics: studies, to proceed, company, prompting, pivotal, successful, infections, bacterial, resistant, multi-drug, fight, being developed, plazomicin, Inc's, Achaogen, (Reuters), succeeds, antibiotic, 1-Achaogen's, UPDATE

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/K0Ev5JVDrII/achaogen-study-idUSL4N1E73EG

UPDATE 1-Ferrari races to new high after earnings top forecast

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:48:11

UPDATE 2-Ralph Lauren CEO to leave after differences with founder

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:24:14

UPDATE 1-Sterling, gilt yields skid as BoE seems in no rush to raise rates

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:03:29

UPDATE 2-Fingerprint Cards suffers fresh setback with weak outlook

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:30:03

UPDATE 3-Daimler pursues new records in tougher environment

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:27:59

Analyzed News